Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Update

Bluejay Diagnostics, Inc. (NASDAQ:BJDXGet Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 6,000 shares, a decline of 80.0% from the February 28th total of 30,000 shares. Currently, 1.1% of the shares of the company are short sold. Based on an average trading volume of 82,900 shares, the short-interest ratio is presently 0.1 days.

Institutional Trading of Bluejay Diagnostics

An institutional investor recently raised its position in Bluejay Diagnostics stock. Anson Funds Management LP raised its holdings in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDXFree Report) by 359.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 319,280 shares of the company’s stock after purchasing an additional 249,770 shares during the quarter. Anson Funds Management LP owned 1.93% of Bluejay Diagnostics worth $41,000 as of its most recent filing with the Securities & Exchange Commission. 18.47% of the stock is owned by institutional investors.

Bluejay Diagnostics Stock Performance

Shares of NASDAQ BJDX traded down $0.11 during midday trading on Wednesday, reaching $3.73. The stock had a trading volume of 27,193 shares, compared to its average volume of 192,197. Bluejay Diagnostics has a 12-month low of $3.03 and a 12-month high of $323.92. The stock has a 50-day moving average of $3.82 and a 200-day moving average of $4.59. The company has a market capitalization of $2.06 million, a price-to-earnings ratio of 0.00 and a beta of 0.38.

Bluejay Diagnostics Company Profile

(Get Free Report)

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.

See Also

Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.